fbpx
Connect with us

News

Irish diagnostics innovator signs UK deal

Avatar photo

Published

on

Serosep has won a contract to supply its gastroenteritis diagnostic test.

Pioneering diagnostics firm Serosep has signed a five-year, £1m contract with Liverpool University Hospital.

Ireland-based Serosep will supply the hospital with its molecular diagnostic solution, EntericBio, used to diagnose gastroenteritis.

Irish Deputy Prime Minister Leo Varadkar welcomed the deal during his trade mission to the UK organised by Enterprise Ireland, the Irish government’s trade, and innovation agency.

Varadkar, who is also Minister for Enterprise, Trade and Employment, said: “Ireland and Britain will always have a close relationship. Our two countries are interlinked in myriad different ways, and we will be looking to strengthen those ties as we emerge from the pandemic and face into future challenges, such as climate change and digitalisation. Irish companies have created over 125,000 jobs in Britain.

“By working closely together, building on existing partnerships and building new ones, we hope to create more jobs and prosperity for both countries.”

Serosep’s new contract was announced during an Enterprise Ireland-hosted health tech innovation  roundtable in London this week.

Serosep, of Limerick, is already working with several UK partners including Public Health Wales, HSL Laboratories (comprising of University College London, Royal Free, North Middlesex Hospital and The Doctors Laboratory), St. Georges Hospital, Imperial College London and Norfolk and Norwich University Hospital.

CEO Dermot Scanlon said: “In the UK, around one in five people gets gastroenteritis each year. As Serosep continues their bid to be the leading laboratory diagnostics specialists in microbiology, histopathology and environmental testing, working with Liverpool University Hospital will pave the way to revolutionising molecular enteric testing worldwide.”

The EntericBio system enables testing, detecting and identifying of pathogens including bacteria, parasites, CPE and viruses within the same workflow and platform with a result for up to 46 specimens per run in less than three hours and results for consecutive runs each hour.

The Serosep test uses robotic processing and artificial intelligent software to assist in the diagnostic process, enabling labs to provide rapid results by eliminating the need for DNA extraction and manual pipetting steps.

The firm works across 30 countries in five continents.

Continue Reading
1 Comment

1 Comment

  1. Pingback: Are we set for a quantum leap in taking diagnostics to patients? - Health Tech World

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories